member
interferoninduc
transmembran
ifitm
protein
famili
inhibit
entri
wide
rang
virus
virus
often
exploit
endocytosi
pathway
invad
host
cell
escap
endocyt
vesicl
often
respons
low
ph
local
endocyt
vesicl
essenti
interfer
cytosol
entri
phdepend
virus
howev
natur
sort
signal
target
vesicl
poorli
defin
studi
report
possess
sort
motif
ie
enabl
undergo
endocytosi
bind
subunit
complex
accumul
plasma
membran
result
either
mutat
deplet
subunit
overexpress
mutant
importantli
block
endocytosi
abrog
abil
inhibit
phdepend
virus
therefor
identifi
critic
sort
signal
name
control
endocyt
traffick
antivir
action
find
also
reveal
endocyt
protein
first
arriv
plasma
membran
endocytos
traffic
late
endosom
act
imped
viru
entri
mani
virus
enter
cell
endocytosi
bind
receptor
cell
surfac
mercer
et
al
addit
lipid
membran
pose
physic
barrier
viru
entri
membraneassoci
protein
deter
viru
entri
alter
biophys
properti
lipid
membran
schoggin
randal
one
exampl
protein
interferoninduc
transmembran
ifitm
protein
inhibit
entri
divers
virus
influenza
viru
iav
flavivirus
filovirus
other
diamond
farzan
perreira
et
al
human
five
ifitm
protein
known
siegrist
et
al
express
osteoblast
particip
bone
miner
matur
moffatt
et
al
function
remain
unknown
hickford
et
al
respond
stimul
type
interferon
lewin
et
al
inhibit
mani
virus
includ
iav
flavivirus
west
nile
viru
dengu
viru
filovirus
ebola
viru
marburg
viru
vesicular
stomat
viru
vsv
sar
coronaviru
reoviru
rift
valley
fever
viru
hepat
c
viru
hcv
jaagsiekt
sheep
retroviru
jsrv
human
immunodefici
viru
type
brass
et
al
jiang
et
al
weidner
et
al
huang
et
al
lu
et
al
schoggin
et
al
chan
et
al
anafu
et
al
vivo
import
antivir
defenc
demonstr
much
higher
mortal
morbid
mice
upon
iav
infect
compar
wildtyp
mice
bailey
et
al
everitt
et
al
addit
hospit
iav
patient
show
signific
enrich
singlenucleotid
polymorph
snp
gene
impair
antiiav
function
everitt
et
al
zhang
et
al
although
associ
snp
mild
influenza
sever
infect
also
report
mill
et
al
one
mechan
vivo
role
express
protect
lung
resid
memori
cell
infect
influenza
virus
well
subsequ
viru
exposur
wakim
et
al
ifitm
protein
caus
accumul
iav
particl
intracellular
acid
membran
compart
ifitm
protein
predominantli
resid
feeley
et
al
huang
et
al
suggest
block
viru
cytosol
entri
inhibit
membran
fusion
ifitm
shown
reduct
cell
cell
fusion
mediat
envelop
protein
iav
jsrv
well
class
ii
iii
fusion
protein
li
et
al
inhibit
cell
fusion
rescu
lipid
analogu
known
oleic
acid
confer
neg
membran
curvatur
promot
membran
hemifus
suggest
ifitm
protein
imped
creation
hemifus
li
et
al
underli
mechan
may
involv
decreas
membran
fluiditi
li
et
al
support
elev
cholesterol
multivesicular
bodi
late
endosom
result
interact
vapa
vesiclemembraneproteinassoci
protein
consequ
dissoci
vapa
cholesterol
sensor
osbp
oxysterolbind
protein
amini
bavilolyae
et
al
ifitm
protein
inhibit
virus
enter
cell
differ
subcellular
site
among
virus
ifitm
inhibit
entri
phindepend
gener
believ
occur
plasma
membran
blumenth
et
al
vsv
iav
phdepend
virus
requir
differ
ph
optima
trigger
viral
membran
fusion
vsv
entri
occur
ph
earli
endosom
wherea
membran
fusion
iav
take
place
ph
late
endosom
lysosom
vazquezcalvo
et
al
order
inhibit
divers
virus
ifitm
protein
need
present
variou
portal
viru
entri
inde
addit
endoplasm
reticulum
er
synthes
modifi
also
locat
plasma
membran
endosom
lysosom
albeit
differ
level
yount
et
al
feeley
et
al
huang
et
al
li
et
al
current
larg
unclear
traffick
itinerari
ifitm
protein
cellular
membran
compart
signal
control
ifitm
traffick
signal
mechan
regul
antivir
action
ifitm
protein
addit
role
palmitoyl
ubiquitin
modul
subcellular
local
yount
et
al
key
role
residu
regard
also
report
jia
et
al
john
et
al
yet
mechan
behind
role
experiment
demonstr
provid
evid
bear
tyrosinebas
classic
sort
signal
locat
enabl
undergo
endocytosi
essenti
inhibit
virus
although
sort
function
per
se
surpris
result
demonstr
endocyt
protein
importantli
properti
essenti
inhibit
phdepend
virus
enter
cell
via
endocytosi
motif
allow
undergo
endocytosi
ntermin
region
contain
tetrapeptid
conform
canon
sort
signal
x
amino
acid
denot
amino
acid
bulki
sidechain
fig
bonifacino
traub
order
determin
whether
function
import
traffick
mutat
conserv
residu
gener
group
mutant
fig
first
character
mutant
examin
subcellular
local
found
contrast
wildtyp
coloc
endocytos
transferrin
mutant
accumul
cell
peripheri
fig
observ
support
previou
find
delet
caus
reloc
plasma
membran
jia
et
al
data
togeth
suggest
import
determin
subcellular
distribut
accumul
mutant
plasma
membran
suggest
plasma
membran
like
one
intermedi
site
wildtyp
en
rout
late
endosom
wildtyp
predominantli
resid
feeley
et
al
demonstr
first
tri
detect
cell
surfac
immunostain
nflag
flag
tag
ad
nterminu
express
cell
follow
incub
cell
antiflag
antibodi
ice
min
wash
unbound
antibodi
fix
cell
imag
cell
surfac
appar
fluoresc
signal
detect
intact
nonpermeabil
cell
although
presenc
intracellular
shown
result
stain
detergentpermeabil
cell
fig
similarli
nflag
ylaa
mutant
undetect
cell
surfac
antiflag
antibodi
stain
although
mutant
clearli
locat
plasma
membran
fig
result
suggest
ntermin
region
locat
within
cytoplasm
consist
publish
data
yount
et
al
bailey
et
al
next
ad
flag
tag
cterminu
perform
experi
contrast
nflag
cflag
version
readili
detect
cell
surfac
antiflag
antibodi
stain
suggest
extracellular
exposur
ctermin
sequenc
fig
surprisingli
cflag
ylaa
mutant
also
detect
cell
surfac
antiflag
antibodi
fig
perform
antibodi
uptak
experi
switch
cell
min
follow
incub
antiflag
antibodi
ice
antiflag
antibodybound
cflag
detect
insid
cell
coloc
endocytos
transferrin
fig
howev
cflag
ylaa
mutant
remain
cell
peripheri
suggest
defect
endocytosi
fig
valid
observ
ad
differ
tag
myc
tag
cterminu
perform
antibodi
uptak
immunostain
experi
cmyc
nmyc
form
detect
antimyc
antibodi
cell
surfac
cmyc
antibodi
complex
intern
follow
incub
fig
b
order
valid
imag
data
show
luminalextracellular
exposur
cterminu
use
flow
cytometri
score
cell
stain
antimyc
antibodi
either
nonpermeabil
condit
cell
surfac
express
permeabil
condit
total
express
equal
number
posit
stain
cell
measur
cmyc
regardless
cell
permeabil
oppos
nmyc
whose
cellsurfac
express
seen
less
cell
fig
data
support
model
type
ii
transmembran
protein
bailey
et
al
order
valid
undergo
endocytosi
treat
cell
endocytosi
inhibitor
dynasor
cpz
macia
et
al
vercauteren
et
al
min
treatment
dynasor
compar
min
treatment
effect
block
endocytosi
transferrin
caus
reloc
plasma
membran
fig
similar
effect
observ
cpz
treatment
fig
togeth
conclud
endocytos
cell
surfac
process
depend
motif
sort
signal
recogn
subunit
ap
complex
five
ap
complex
discov
among
well
character
bonifacino
traub
hirst
et
al
ap
one
subunit
except
two
isoform
determin
subunit
recogn
motif
express
along
protein
immunoprecipit
antimyc
antibodi
presenc
precipit
materi
examin
western
blot
result
show
coimmunoprecipit
subunit
evid
subunit
test
fig
demonstr
interact
mediat
motif
mutant
chang
peptid
motif
test
coimmunoprecipit
none
mutant
associ
subunit
fig
notic
mutant
except
migrat
slower
wild
type
may
result
alter
protein
fold
andor
loss
modif
test
two
mutant
wraa
fda
pocket
mutat
carvajalgonzalez
et
al
observ
interact
two
mutant
wildtyp
fig
togeth
data
demonstr
yemldepend
interact
subunit
specif
interact
may
result
either
frequent
traffick
plasma
membran
endosom
andor
high
affin
yeml
motif
yeml
mutat
motif
highlight
boldfac
letter
unfil
box
denot
two
put
membran
domain
b
effect
mutat
yeml
motif
cellular
local
cell
transfect
yeml
mutant
fed
alexa
transferrin
min
prior
fixat
protein
stain
antiflag
primari
antibodi
fitcconjug
secondari
antibodi
dapi
use
stain
nuclei
c
undergo
endocytosi
cell
express
cflag
ylaa
mutant
incub
antiflag
antibodi
min
presenc
alexa
transferrin
cell
either
fix
directli
stain
antiflag
antibodi
cell
surfac
express
switch
min
allow
intern
antibodi
complex
antibodi
uptak
intern
complex
visual
stain
fitcconjug
secondari
antibodi
visual
total
ylaa
mutant
total
express
cell
permeabil
saponin
prior
immunostain
antiflag
antibodi
wildtyp
two
exposur
imag
present
show
rel
weak
stain
plasma
membran
repres
imag
shown
cell
surfac
express
nand
ctermini
cell
transfect
cmyc
ylaa
mutant
dna
half
cell
incub
antimyc
antibodi
stain
cterminu
cell
surfac
half
fix
permeabil
saponin
follow
antimyc
antibodi
stain
total
express
mycposit
cell
score
flow
cytometri
ratio
mycposit
cell
cell
surfac
stain
total
express
stain
calcul
determin
rel
cellsurfac
exposur
nand
ctermini
averag
three
independ
experi
summar
bar
graph
endocytosi
antivir
activ
subunit
data
complet
exclud
possibl
weak
interact
subunit
support
possibl
shown
spite
high
affin
yevm
motif
lysosom
protein
subunit
mutat
misloc
plasma
membran
reveal
interact
yevm
absenc
wildtyp
rou
et
al
next
ask
subunit
function
involv
endocytosi
first
examin
effect
two
mutant
wraa
fda
subcellular
distribut
contrast
ectop
express
wildtyp
subunit
affect
intracellular
local
wraa
fda
mutant
caus
accumul
cell
peripheri
like
result
disrupt
function
endogen
complex
fig
next
knock
sirna
oligo
fig
examin
cellular
distribut
affect
result
show
knockdown
effect
block
endocytosi
transferrin
fig
sirna
treatment
led
accumul
cell
peripheri
fig
although
none
four
sirna
oligo
complet
deplet
endogen
fig
intern
transferrin
drastic
reduc
suggest
level
key
determin
endocytosi
effici
extend
studi
knock
hela
cell
observ
concomit
blockad
transferrin
endocytosi
endogen
reloc
intracellular
compart
plasma
membran
fig
taken
togeth
conclud
subunit
complex
function
requir
endocytosi
next
examin
whether
antivir
action
depend
integr
motif
context
gener
cell
line
stabli
express
either
wildtyp
mutant
alter
sequenc
challeng
cell
iav
assess
viru
infect
measur
level
iav
protein
np
ha
western
blot
drastic
decreas
level
np
ha
observ
cell
compar
control
cell
fig
contrast
similar
level
iav
infect
observ
control
cell
cell
express
mutant
fig
loss
iav
inhibit
mutant
due
poor
express
express
well
wildtyp
fig
assess
antiiav
activ
wildtyp
mutant
use
variou
dose
iav
infect
score
viral
npposit
cell
flow
cytometri
lowest
dose
iav
infect
cell
reduc
number
infect
cell
wherea
ylaa
mutant
exhibit
threefold
inhibit
fig
fig
highest
dose
virus
infect
twentyfour
hour
transfect
cell
treat
dynasor
cpz
ml
b
differ
period
time
follow
immunostain
treatment
dynasor
cpz
cell
also
incub
alexa
transferrin
ml
min
monitor
effect
treatment
endocytosi
subcellular
local
determin
stain
antiflag
antibodi
nuclei
stain
dapi
repres
imag
shown
cell
still
strongli
inhibit
iav
infect
oppos
ylaa
mutant
complet
lost
inhibitori
effect
fig
fig
test
mutat
motif
affect
inhibit
viral
infect
mediat
vsv
g
protein
phdepend
entri
ebola
viru
gp
protein
phdepend
entri
well
mlv
protein
phindepend
entri
mutat
yeml
disabl
inhibit
vsv
g
ebola
gpmediat
infect
fig
notic
inhibit
infect
ylaa
mutant
exert
moder
inhibitori
effect
fig
togeth
data
demonstr
motif
import
inhibit
phdepend
viru
entri
known
conserv
mani
speci
hickford
et
al
align
sequenc
reveal
presenc
yemllik
motif
similar
locat
ntermin
region
fig
among
coimmunoprecipit
subunit
cell
transfect
plasmid
dna
express
myctag
subunit
protein
immunoprecipit
antimyc
antibodi
follow
western
blot
indic
antibodi
b
coimmunoprecipit
examin
associ
mutant
yeml
sequenc
alter
c
coimmunoprecipit
detect
interact
mutant
wraa
fda
bear
mutat
pocket
size
protein
marker
kda
shown
left
side
western
blot
four
amino
acid
met
appear
least
conserv
order
test
whether
sequenc
diverg
affect
antivir
activ
exchang
motif
human
yeml
mous
yeri
determin
chang
affect
abil
inhibit
iav
infect
wildtyp
mutat
protein
express
similar
level
except
yeml
motif
diminish
protein
migrat
sdspage
fig
nevertheless
exchang
motif
affect
antiiav
abil
either
human
mous
fig
suggest
function
interchang
result
studi
suggest
motif
act
function
proteinsort
signal
interact
subunit
complex
allow
undergo
endocytosi
fig
given
mani
virus
exploit
endocytosi
enter
cell
mercer
et
al
traffick
along
endocytosi
pathway
provid
opportun
encount
inhibit
virus
fig
regardless
whether
viru
hijack
clathrindepend
clathrinindepend
endocytosi
rout
mercer
et
al
endocytos
vesicl
ultim
fuse
endosom
compart
deliv
cargo
includ
intern
viral
particl
late
endosom
lysosom
major
molecul
locat
feeley
et
al
subcellular
local
allow
interfer
entri
divers
virus
enter
cell
via
differ
endocytosi
pathway
differ
virus
penetr
cellular
membran
differ
intracellular
site
earli
endosom
vsv
other
late
endosomeslysosom
iav
ebov
fig
vazquezcalvo
et
al
extent
suscept
restrict
like
vari
among
differ
virus
one
interest
exampl
resist
arenavirus
restrict
like
result
entri
via
clathrinand
caveolinindepend
endocytosi
pathway
brass
et
al
subcellular
local
traffick
influenc
posttransl
modif
three
type
posttransl
modif
report
first
spalmitoyl
cystein
yount
et
al
mutat
cystein
affect
local
er
diminish
membranebind
cluster
properti
result
antivir
action
abrog
yount
et
al
john
et
al
second
ubiquitin
lysin
major
acceptor
ubiquitin
yount
et
al
oppos
spalmitoyl
elimin
ubiquitin
mutat
lysin
residu
promot
local
late
endosom
concomitantli
enhanc
antivir
activ
yount
et
al
one
possibl
explan
ubiquitin
occlud
iav
use
infect
cell
stabli
express
mutant
alter
yeml
sequenc
eight
hour
infect
cell
lyse
level
iav
protein
np
ha
determin
western
blot
antiflag
antibodi
use
probe
ectop
express
mutant
size
protein
marker
shown
left
side
western
blot
b
differ
dose
iav
use
infect
cell
line
eight
hour
infect
infect
cell
fix
stain
antinp
antibodi
follow
flow
cytometri
analysi
score
infect
cell
result
shown
averag
three
independ
infect
origin
flow
cytometri
data
present
supplement
fig
c
effect
wildtyp
mutant
infect
mediat
vsv
g
protein
ebola
viru
gp
protein
mlv
cell
infect
mlvgfp
report
virus
pseudotyp
vsvg
ebov
gp
protein
gfpposit
cell
score
flow
cytometri
h
infect
result
shown
averag
three
independ
experi
pvalu
calcul
data
wildtyp
mutant
number
infect
mediat
vsv
g
ebov
gp
endocytosi
antivir
activ
recognit
proxim
sort
motif
subunit
complex
thu
impair
endocytosi
fig
lastli
amino
acid
phosphoryl
fyn
tyrosin
kinas
jia
et
al
given
tyrosin
phosphoryl
motif
hinder
recognit
consequ
imped
endocytosi
bonifacino
traub
like
phosphoryl
serv
mechan
cell
regul
endocytosi
effici
subcellular
local
conserv
yemllik
motif
protein
differ
speci
consensu
sequenc
ymotif
shown
b
contain
yeri
motif
mous
yeml
motif
human
cell
line
gener
stabli
express
protein
pqcxip
empti
retrovir
vector
use
produc
control
cell
line
fig
model
illustr
intracellular
traffick
antivir
action
follow
synthesi
er
traffic
plasma
membran
motif
interact
subunit
complex
undergo
clathrindepend
endocytosi
ubiquitin
shown
palmitoyl
traffick
mechan
posit
endocyt
pathway
mani
virus
util
cell
entri
exampl
virus
vsv
iav
ebov
mlv
phindepend
viru
vsv
vesicular
stomat
viru
iav
influenza
viru
ebov
ebola
viru
mlv
murin
leukaemia
viru
model
partial
adapt
publish
bailey
et
al
diamond
farzan
perreira
et
al
critic
role
antivir
activ
report
studi
delet
first
amino
acid
prevent
inhibit
vsv
iav
everitt
et
al
loss
viru
inhibit
recapitul
mutat
jia
et
al
john
et
al
addit
snp
significantli
enrich
hospit
patient
suffer
season
pandem
influenza
virus
everitt
et
al
zhang
et
al
snp
caus
aberr
splice
mrna
creat
mutant
lack
first
amino
acid
discov
function
sort
signal
provid
molecular
mechan
behind
key
role
antivir
activ
report
studi
note
bear
yeml
motif
yet
still
exert
antivir
activ
postul
ctermin
sequenc
bear
yhim
motif
may
control
traffick
antivir
function
result
studi
support
type
ii
transmembran
topolog
recent
report
bailey
et
al
two
membran
topolog
previous
document
one
model
stipul
dualpass
transmembran
protein
luminalextracellular
exist
nand
ctermini
model
support
result
cell
surfac
immunostain
flow
cytometri
experi
show
detect
flag
tag
attach
nterminu
second
model
describ
intramembran
protein
termini
project
toward
cytoplasm
support
latter
membran
topolog
none
put
glycosyl
site
within
distal
ctermin
region
modifi
yount
et
al
furthermor
residu
ntermin
region
ubiquitin
occur
expos
intracellular
ligas
result
support
cytoplasm
resid
ntermin
region
sinc
cell
surfac
stain
antiflag
antimyc
antibodi
bare
detect
ntermin
tag
meantim
abl
readili
detect
cell
surfac
flag
myc
tag
ad
cterminu
support
luminalextracellular
exposur
ctermin
region
fig
support
lumin
resid
cterminu
append
er
retent
signal
kdel
lead
er
sequestr
bailey
et
al
moreov
cterminu
nterminu
subject
lysosom
degrad
bailey
et
al
studi
warrant
reconcil
differ
observ
possibl
topolog
membran
may
dynam
natur
depend
differ
posttransl
modif
differ
cell
type
plasmid
describ
previous
jia
et
al
mutant
ylaa
yeri
yeml
yeqf
yqrl
yevm
ytrf
gener
pcrbase
mutagenesi
method
pcrbase
method
also
use
add
flag
tag
cterminu
myc
tag
cterminu
pcr
primer
list
tabl
express
vector
gift
stephen
ferguson
seachrist
et
al
plasmid
kindli
provid
juan
bonifacino
heik
folsch
et
al
carvajalgonzalez
et
al
myc
tag
ad
cterminu
subunit
detect
western
blot
immunofluoresc
stain
two
mutant
wraa
fda
gener
pcrbase
mutagenesi
use
primer
list
tabl
transfect
plasmid
dna
cell
perform
lipofectamin
invitrogen
accord
manufactur
instruct
antibodi
cat
number
purchas
novu
biolog
antibodi
cat
number
proteintech
antinp
antibodi
influenza
nucleoprotein
cat
number
millipor
antiflag
antibodi
cat
number
sigma
antimyc
cat
number
antiiav
cat
number
antiha
antibodi
cat
number
santa
cruz
fitcand
tritcconjug
secondari
antibodi
cat
number
purchas
jackson
immunoresearch
laboratori
chlorpromazin
cpz
cat
number
saponin
cat
number
dynasor
cat
number
purchas
sigma
first
retroviru
particl
prepar
transfect
cell
dna
pcmvmlvgagpol
dna
pvsvg
dna
h
supernat
collect
centrifug
rpm
remov
cell
debri
cell
infect
harvest
viru
particl
present
ml
polybren
spinocul
rpm
min
room
temperatur
twentyfour
hour
infect
cell
select
complet
dmem
medium
contain
ml
puromycin
sigma
iav
infect
conduct
follow
cell
express
yeml
mutant
first
wash
phosphatebuff
salin
expos
variou
dose
iav
strain
dilut
influenza
viru
growth
medium
optimem
contain
fb
one
hour
infect
viral
inoculum
wash
growth
medium
cell
maintain
growth
medium
hour
detach
mm
edta
infect
cell
lyse
subject
western
blot
antiflag
ha
np
antibodi
altern
cell
fix
formaldehyd
phosphatebuff
salin
permeabil
triton
min
immunostain
antinp
antibodi
infect
cell
score
flow
cytometri
infect
mlvgfp
report
virus
perform
previous
describ
jia
et
al
briefli
report
virus
produc
transfect
cell
plasmid
dna
pcmvgagpolmlv
pcmvgfpmlv
pvsvg
pebovgp
virus
use
infect
cell
line
express
mutant
infect
cell
score
gfpposit
cell
flow
cytometri
cell
lyse
lysi
buffer
contain
mm
tri
ph
mm
nacl
mm
edta
triton
proteas
inhibitor
cocktail
roch
cell
debri
remov
centrifug
cell
lysat
incub
antimyc
antibodi
h
ice
protein
resin
millipor
ad
overnight
incub
three
time
wash
lysi
buffer
bound
protein
extract
load
buffer
contain
sd
min
protein
sampl
examin
western
blot
follow
antibodi
antiflag
antimyc
antinp
antiha
cell
seed
polylysineco
glass
slide
day
transfect
plasmid
dna
express
mutant
forti
hour
transfect
cell
incub
alexa
transferrin
invitrogen
ml
serumfre
dmem
min
wash
phosphatebuff
salin
cell
first
fix
formaldehyd
min
room
temperatur
permeabil
triton
min
incub
block
buffer
contain
bsa
skim
milk
cell
stain
antiflag
antimyc
primari
antibodi
dilut
h
room
temperatur
follow
fitcor
tritcconjug
secondari
antibodi
dilut
min
room
temperatur
dapi
util
stain
nuclei
imag
captur
use
leica
tc
laser
scan
confoc
microscop
cell
first
transfect
plasmid
dna
h
treat
either
dynasor
min
cpz
ml
min
cell
fix
immunostain
describ
monitor
effect
dynasor
cpz
treatment
endocytosi
cell
incub
alexa
transferrin
ml
min
cell
wash
phosphatebuff
salin
fix
formaldehyd
examin
confoc
microscop
antibodi
uptak
assay
cell
transfect
plasmid
dna
express
flagtag
ylaa
mutant
flag
tag
attach
either
cterminu
forti
hour
transfect
cell
wash
phosphatebuff
salin
incub
antiflag
antibodi
alexa
transferrin
ml
serumfre
dmem
min
wash
serumfre
dmem
cell
incub
min
fix
formaldehyd
intern
complex
detect
permeabil
cell
triton
stain
fitcconjug
secondari
antibodi
imag
record
use
leica
tc
laser
scan
confoc
microscop
hela
cell
seed
glass
slide
plate
day
transfect
sirna
pmol
well
use
lipofectamin
invitrogen
two
sequenti
sirna
transfect
cell
fed
ml
alexa
transferrin
min
fix
immunofluoresc
stain
antibodi
describ
level
endogen
determin
western
blot
antibodi
mediat
resist
influenza
viru
j
biol
chem
zhang
yh
zhao
li
n
peng
yc
giannoulat
e
jin
rh
et
al
interferoninduc
transmembran
genet
variant
associ
sever
influenza
chines
individu
nat
commun
addit
support
inform
may
found
onlin
version
articl
publish
websit
fig
nflag
stain
antiflag
antibodi
cell
surfac
nflag
ylaa
express
cell
detail
legend
refer
fig
fig
detect
endocytosi
cmyc
antibodi
uptak
assay
myc
tag
ad
cterminu
ylaa
mutant
cell
surfac
stain
cmyc
ylaa
mutant
antimyc
antibodi
wildtyp
ylaa
abl
undergo
endocytosi
b
antimyc
antibodi
detect
nmyc
cell
surfac
fig
result
flow
cytometri
analysi
iavinfect
cell
express
mutant
ylaa
data
summar
fig
amount
iav
use
infect
indic
cell
harvest
h
post
infect
immunostain
antinp
antibodi
tabl
list
primer
use
mutagenesi
clone
endocytosi
antivir
activ
